About this trial
The study is an exploratory study that aims to explore the incidence of heart failure in a national surgical cohort, and to compare postoperative mortality and morbidity in patients with and without heart failure. Furthermore, we want to investigate differences in the incidence of heart failure and its impact on postoperative morbidity and mortality in day surgery compared to inpatient surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
≥18 years of age who underwent surgery in Sweden between 1 Jan 2021-31 Dec 2024 and SPOR registered operation.
Disqualifiers
ASA 6 (deceased patient, organ donation).
Cardiac surgery
Trial population
Patients ≥18 years of age who underwent surgery in Sweden between 1 Jan 2021-31 Dec 2024.
Trial design
Cohort
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Postoperative mortality
How does a heart failure diagnosis affect postoperative mortality at 30 days, 90 days, 180 days, and 365 days?
Postoperative morbidity
How does a heart failure diagnosis associated with postoperative morbidity at 30 days?
Secondary outcomes
Prevalence of heart failure
What is prevalence of heart failure in surgery in Sweden?
Other outcomes
Differences between ambulatory and inpatient surgery
Is there difference between ambulatory respective elective surgery regarding mortality and morbidity after surgery?
Difference in prevalence of heart failure
Is there difference in prevalence regarding ambulatory and inpatient surgery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Umeå University
Lead sponsor
Region Norrbotten
Collaborator
This trial is not recruiting at the moment. You can still explore other options: